The results showing that VXX-401 elicited a IgG1-dominant response were therefore anticipated, given its nature as a synthetic peptide-based vaccine, and reveal a notable lack of proinflammatory subclasses (i.e., IgG3) and those with known pathogenic roles in autoimmune diseases (25, 26). The gene discussed is IGHG3; the disease is autoimmune disease.